Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.

Primo Partners with SHINE to Advance Precision Cancer Care in Asia-Pacific Primo partners with SHINE to bring Ilumira to Asia-Pacific, advancing radioligand therapy and precision cancer care with exclusive rights in key markets.

Molybdenum-99 Market is projected to cross US$ 7.28 billion at an amazing CAGR of 5% by 2033 end | Research analysis by Future Market Insights, Inc. NEWARK, Del, March 30, 2023 (GLOBE NEWSWIRE) -- The molybdenum-99 market is predicted to be worth US$ 4.48 billion in 2023 and rise to US$ 7.28 billion by 2033. Initially, the global market was...